Blake Neil Schroeder - 10 Feb 2022 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Director
Signature
/s/ Blake Neil Schroeder
Issuer symbol
AXIM
Transactions as of
10 Feb 2022
Net transactions value
+$625,000,000
Form type
4
Filing time
15 Feb 2022, 17:04:17 UTC
Next filing
26 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Convertible Note (Convertible into Common Stock) Other $625,000,000 +25,000 +8.8% $25000.00* 307,692 10 Feb 2022 Common Stock 307,692 $0.0812 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Note bears interest at a rate of 3% per annum. At the election of the Reporting Person, all principal and accrued interest under the Note may be converted into the Issuer's common stock at a converstion price equal to the lesser of $0.08125 or 70% of the average of the two lowest closing prices of the Issuer's common stock in the ten (10) days prior to the date of conversion.